← Back to Analyst Consensus 
NTLA Hold
Intellia Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 24
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 6, 2026 | Barclays | initiate | — → Underweight | — | 53% |
| Sep 9, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 46% |
| Sep 9, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Sep 9, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 25, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 46% |
| Aug 7, 2026 | Evercore ISI Group | upgrade | In-Line → Outperform | — | 58% |
| Jul 16, 2026 | Wolfe Research | downgrade | Peer Perform → Underperform | — | 53% |
| Jul 10, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Jun 16, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jun 15, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 46% |
| Jun 15, 2026 | Wedbush | reiterate | Neutral → Neutral | — | 58% |
| Jun 15, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 13, 2026 | Bernstein | maintain | Market Perform → Market Perform | — | 52% |
| May 13, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 12, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| May 12, 2026 | Wedbush | reiterate | Neutral → Neutral | — | 58% |
| Apr 28, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Apr 28, 2026 | Goldman Sachs | maintain | Sell → Sell | — | 54% |
| Apr 28, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Apr 28, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 46% |
| Apr 27, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Apr 27, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Mar 4, 2026 | Jones Trading | upgrade | Hold → Buy | — | 50% |
| Mar 3, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Mar 3, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| Mar 3, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | — | 55% |
| Mar 3, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Mar 3, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 46% |
| Mar 3, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 2, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Feb 27, 2026 | Chardan Capital | maintain | Buy → Buy | $26 | 47% |
| Jan 28, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $25 | 44% |
| Nov 12, 2025 | Wolfe Research | downgrade | Outperform → Peer Perform | $0 | 53% |
| Nov 11, 2025 | Jones Trading | downgrade | Buy → Hold | $0 | 50% |
| Nov 11, 2025 | Evercore ISI Group | downgrade | Outperform → In-Line | $8 | 58% |
| Nov 10, 2025 | Truist Securities | reiterate | Buy → Buy | $14 | 54% |
| Nov 10, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $15 | 44% |
| Nov 7, 2025 | Chardan Capital | maintain | Buy → Buy | $26 | 47% |
| Nov 7, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $9 | 55% |
| Nov 7, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $12 | 54% |
| Nov 7, 2025 | Barclays | maintain | Overweight → Overweight | $14 | 53% |
| Nov 7, 2025 | Wedbush | maintain | Neutral → Neutral | $7 | 58% |
| Nov 7, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $21 | 46% |
| Nov 7, 2025 | JP Morgan | downgrade | Neutral → Underweight | $5 | 55% |
| Oct 30, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $18 | 44% |
| Oct 28, 2025 | Wells Fargo | downgrade | Overweight → Equal-Weight | $17 | 54% |
| Oct 28, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $29 | 53% |
| Oct 28, 2025 | Barclays | maintain | Overweight → Overweight | $24 | 53% |
| Oct 28, 2025 | RBC Capital | downgrade | Outperform → Sector Perform | $14 | 55% |
| Oct 28, 2025 | Bernstein | downgrade | Outperform → Market Perform | $14.5 | 52% |
Price Target Trend
Jun 1, 2026 Oct 26, 2026
EPS Estimates
+1q —
+1y —
0y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days